Zoledronic Acid Hydrate

Zoledronic acid (zoledronate) is a bisphosphonate bone resorption inhibitor, an inhibitor of farnesyl diphosphate (FPP) synthase which results in downstream inhibition of osteoclast activity and reduced bone resorption and turnover. It has been used to treat postmenopausal osteoporosis, Paget's disease, hypercalcemia, and along with cancer chemotherapy to treat bone damage caused by cancer that has spread to the bones.
Supplier BOC Sciences
Product # 165800-06-6
Pricing Inquire
Cas 165800-06-6
Molecular Weight 290.1
Molecular Formula C5H12N2O8P2
Canonical SMILES C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O.O
Feedback